Welcome Message from the Chairman Chairman
Hong-Gyun Wu

Dear Members and Visitors,

It is a great honor to serve as the new Chairman of the Korean Association for Lung Cancer (KALC), and I extend a warm welcome to all. Lung cancer remains one of the most pressing health challenges, and our society is fully committed to conquering this disease through a comprehensive, multidisciplinary approach involving the expertise of various specialists.

The KALC is unique in bringing together a wide array of professionals, including specialists in respiratory medicine, thoracic surgery, radiation oncology, medical oncology, radiology, pathology, and nuclear medicine, etc. This diversity enables us to create a truly collaborative environment, where members from different fields share insights and develop optimal strategies to improve lung cancer care. Furthermore, we are strengthened by two dedicated research groups: the Targeted Therapy Research Group and the Tumor Immunology Multidisciplinary Research Group, both of which focus on applying cutting-edge treatments, including targeted therapies and immunotherapy, to provide the most effective options for lung cancer patients.

As Chairman, I am committed to supporting these collaborative efforts within KALC and enhancing opportunities for academic exchange and camaraderie among our members. Together, through our dedication to innovation and our multidisciplinary collaborations, I am confident that we can make significant strides in the fight against lung cancer. Thank you for your continued support and engagement as we work toward a brighter future in lung cancer care.

Sincerely,
Hong-Gyun Wu
Chairman, Korean Association for Lung Cancer